ARTICLE | Clinical News
Autologous vaccine: Began Phase Ib trial
September 17, 2001 7:00 AM UTC
Biomira Inc. (BIOM; TSE:BRA), Edmonton, Alberta Product: Autologous vaccine Business: Cancer Therapeutic category: Immune stimulation Target: Immune cells Description: Autologous cancer antigen vacci...